why choose us

First received: December 06, 2022

Clinical Trial: PET/CT Characterization of Treatment Resistance

Study Status: Completed

Recruit Status: RECRUITING

Condition: Prostate Cancer

Study Type: INTERVENTIONAL


Official Title: PET/CT Characterization of Treatment Resistance of AR-targeted Therapies in mCRPC

Brief Summary: This study will use different types of medical imaging to assess how lesions from advanced prostate cancer become resistant to second-generation AR-targeted therapy, and how the different types of imaging compare in that assessment.Participants in this study have advanced prostate cancer and are either scheduled to start a second-generation androgen receptor (AR) targeted therapy (such as enzalutamide, abiraterone, or apalutamide) or are already being treated with one.Participants can expect to be in the study for…

Read more